- Home
- EDSA vs REBN Comparison
EDSA vs REBN Comparison
Compare EDSA & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- REBN
- Stock Information
- Founded
- EDSA 2015
- REBN 2015
- Country
- EDSA Canada
- REBN United States
- Employees
- EDSA N/A
- REBN N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- REBN Restaurants
- Sector
- EDSA Health Care
- REBN Consumer Discretionary
- Exchange
- EDSA Nasdaq
- REBN Nasdaq
- Market Cap
- EDSA 13.8M
- REBN 8.6M
- IPO Year
- EDSA N/A
- REBN 2022
- Fundamental
- Price
- EDSA $4.23
- REBN $2.55
- Analyst Decision
- EDSA Strong Buy
- REBN
- Analyst Count
- EDSA 2
- REBN 0
- Target Price
- EDSA $39.00
- REBN N/A
- AVG Volume (30 Days)
- EDSA 13.5K
- REBN 24.5K
- Earning Date
- EDSA 08-09-2024
- REBN 11-12-2024
- Dividend Yield
- EDSA N/A
- REBN N/A
- EPS Growth
- EDSA N/A
- REBN N/A
- EPS
- EDSA N/A
- REBN N/A
- Revenue
- EDSA N/A
- REBN $6,203,705.00
- Revenue This Year
- EDSA N/A
- REBN $163.82
- Revenue Next Year
- EDSA N/A
- REBN $64.55
- P/E Ratio
- EDSA N/A
- REBN N/A
- Revenue Growth
- EDSA N/A
- REBN 42.94
- 52 Week Low
- EDSA $2.50
- REBN $0.92
- 52 Week High
- EDSA $6.46
- REBN $8.80
- Technical
- Relative Strength Index (RSI)
- EDSA 38.31
- REBN 34.94
- Support Level
- EDSA $4.00
- REBN $2.27
- Resistance Level
- EDSA $4.44
- REBN $2.76
- Average True Range (ATR)
- EDSA 0.24
- REBN 0.20
- MACD
- EDSA -0.03
- REBN -0.02
- Stochastic Oscillator
- EDSA 4.77
- REBN 34.17
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.